• FITC Goat Anti-Mouse IgG (H+L) Antibody for Sensitive Detect

  2026-07-17

  The FITC Goat Anti-Mouse IgG (H+L) Antibody empowers researchers with robust, highly specific fluorescent detection in immunofluorescence and flow cytometry. Its affinity purification and FITC conjugation enable superior signal amplification and reproducibility for advanced multi-omics and cellular assays.

• Potassium Iodide in Research: Protocols and Immunotherapy Ad

  2026-07-17

  Potassium Iodide (KI) is essential for both thyroid modulation and as a workflow enhancer in cutting-edge immunotherapy research. This article delivers actionable protocols, experimental troubleshooting, and a translation of recent breakthroughs in nanotechnology-driven cancer therapy, setting APExBIO’s KI apart for robust, cross-domain scientific applications.

• Antimycin A4: ATP-Citrate Lyase Inhibitor for Advanced Metab

  2026-07-16

  Antimycin A4’s unique dual inhibition of ATP-citrate lyase and the mitochondrial respiratory chain empowers researchers to dissect complex energy and lipid metabolism in one streamlined workflow. Leveraging protocol insights, troubleshooting strategies, and comparative literature, this guide helps maximize reproducibility and experimental clarity with APExBIO’s trusted compound.

• Olsalazine Sodium: Molecular Transport, Tumor Biology, and V

  2026-07-16

  Explore how Olsalazine Sodium, a potent mesalamine dimer, advances both inflammation research and emerging vector-borne disease strategies. This article delivers a unique perspective by unraveling its dual roles in colorectal cancer tumor models and mosquito xenobiotic transport, with actionable insights for experimental design.

• XAV-939 in Fibrosis and Cardiac Remodeling: Beyond Wnt Inhib

  2026-07-15

  Explore how XAV-939, a potent tankyrase inhibitor, uniquely advances fibrotic disease and cardiac remodeling research. This article analyzes its mechanism and applications, contrasting prior cancer-centric content, and integrates new insights from single-cell cardiac studies.

• Safeguarding Protein Integrity: EDTA-Free Protease Inhibitor

  2026-07-15

  This thought-leadership article explores the mechanistic reasons and strategic imperatives for using EDTA-free protease inhibitor cocktails—specifically APExBIO’s Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO)—in translational research. Anchored in recent findings on ITGB5-mediated metastasis in tongue squamous cell carcinoma, we examine how meticulous protease inhibition underpins the fidelity of protein extraction, post-translational modification analysis, and biomarker validation. The article interweaves cutting-edge oncology insights with practical guidance for researchers designing robust, phosphorylation-sensitive workflows, while benchmarking APExBIO’s offering against the broader competitive landscape.

• KR-12 (Human) TFA: Mechanisms and Translational Frontiers

  2026-07-14

  Explore the multifaceted bioactivity and therapeutic potential of the KR-12 human antimicrobial peptide. This in-depth review reveals novel mechanistic insights and translational applications, setting a new benchmark for KR-12 research.

• Diminazene Aceturate in Parasitic and ACE2 Activation Resear

  2026-07-14

  Diminazene Aceturate stands out for its dual application: a gold-standard tool for trypanosome parasite studies and a validated pharmacological activator of ACE2-mediated mitochondrial biogenesis in sepsis models. This guide demystifies advanced workflows, troubleshooting, and the translational impact of this versatile research compound.

• FKBP9 Drives Glioblastoma Aggression and ER Stress Resistanc

  2026-07-13

  Xu et al. (2020) reveal that FKBP9 promotes glioblastoma malignancy and mediates resistance to endoplasmic reticulum stress inducers by modulating the IRE1α-XBP1 pathway and p38MAPK signaling. These findings clarify FKBP9’s oncogenic function and highlight pivotal signaling axes that may inform new therapeutic strategies.

• LMO2–LDB1 Complex Drives AML Progression: Mechanistic Insigh

  2026-07-13

  This study establishes the LMO2–LDB1 protein complex as a critical oncogenic driver in acute myeloid leukemia (AML), revealing its necessity for leukemic cell proliferation and survival. By integrating molecular interaction assays and functional genomics, the authors highlight the therapeutic potential of targeting this complex for AML intervention.

• Morin: Applied Protocols for Disease Models and Ion Detectio

  2026-07-12

  Morin, a versatile 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, empowers researchers with robust tools for mitochondrial modulation, anti-inflammatory flavonoid studies, and sensitive aluminum ion detection. This guide distills actionable workflows, troubleshooting insights, and translational applications for Morin, with direct connections to real-world disease modeling and biochemical assay optimization.

• Type III Collagen Restricts Breast Tumor Growth and Metastas

  2026-07-10

  The referenced study demonstrates that type III collagen (Col3) in the breast cancer microenvironment acts as a tumor-restrictive matrix component, suppressing tumor growth and metastasis. These findings highlight the prognostic value of Col3:Col1 ratios and suggest that therapeutic strategies enhancing Col3 could improve outcomes in breast cancer patients.

• Cholecystokinin Octapeptide Ammonium: Advancing Neuro-Immune

  2026-07-09

  Cholecystokinin octapeptide ammonium (CCK-8 ammonium) unlocks precise neurobehavioral and immune modeling, enabling researchers to dissect anxiety, apoptosis, and peptide signaling with reproducibility. This guide details evidence-based workflows, protocol refinements, and troubleshooting insights to maximize its impact in translational research.

• Pterostilbene Enhances Mitophagy to Delay Fibroblast Senesce

  2026-07-09

  Zhou et al. (2025) reveal that pterostilbene mitigates senescence in human dermal fibroblasts by promoting mitophagy and restoring mitochondrial function. This study highlights mitochondrial quality control as a promising target for interventions against skin aging and provides mechanistic insights for future anti-aging research.

• 2-NBDG Glucose Uptake Assay Kit: Precision for Metabolic Res

  2026-07-08

  The 2-NBDG Glucose Uptake Assay Kit empowers researchers with rapid, non-radioactive quantitation of glucose uptake at single-cell resolution. Its optimized workflow and built-in specificity controls make it indispensable for studies targeting cancer metabolism, drug resistance mechanisms, and metabolic disease modeling.

450 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page